LactoSpore® is a spore-forming strain, B. coagulans MTCC 5856. It is stable at room temperatures for three years. It is available in strengths of 6 billion CFU/g and 15 billion CFU/g, even up to 100 billion CFU/g and is GMO-free, dairy-free, gluten-free and antibiotic-free. With acknowledgement from FDA for its GRAS, LactoSpore can be safely used in all types of foods, confectionaries and beverages.
About Dr. Anurag Pande
Dr. Pande has been with Sabinsa’s sister company, Sami Labs, since 2004 in a research capacity, and spent several years at Sabinsa Japan’s Tokyo office as Senior Technical Manager. Today, Dr. Pande works from Sabinsa’s Corporate HQ based in East Windsor, New Jersey, USA. Dr. Pande holds a Ph.D. in Phytochemistry from RML Awadh University. He has master of science and bachelor of science degrees from Lucknow University. He is the author of several trade and peer-reviewed publications. By applying his chemistry knowledge to the ingredients Sabinsa promotes, he brings a refreshing viewpoint of understanding how these ingredients work. In his current capacity, Dr. Pande helps with technical marketing, delivers talks on various health benefits, provides worldwide regulatory support of Sabinsa’s portfolio of ingredients, as well as closely working with customers to help them develop new products and formulations in a timely manner.
Sabinsa’s mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 30 years, Sabinsa has brought to market more than 100 standardized botanical extracts, and privately funded clinical studies, in conjunction with prestigious institutions, in support of these products. With more than 100 full-time scientists conducting ongoing research in India and the United States, Sabinsa and parent company Sami Labs Ltd. continue to develop, patent and manufacture phytonutrients for the world market, with ingredients that are both Halal and Kosher. For more information, visit www.sabinsa.com.